ContextLogic Holdings Inc. · OTC:LOGC
ContextLogic — Merger or Acquisition (August 2026)
24 slides from ContextLogic's merger presentation, Aug 5, 2026
Slide 1: Acquisition of gChem
Acquisition of gChem August 2026 Exhibit 99.2
Slide 2: Disclaimer About Forward-Looking Statements & Third-Party Sources
Disclaimer About Forward-Looking Statements & Third-Party Sources 2 This presentation (this “Investor Presentation”) is provided for informational purposes only and has been prepared to assist interested parties in making their own evaluation with respect to a potential transaction (the “Transaction
Slide 3: Disclaimer: Non-GAAP Financial Measures; Industry and Market Data
Disclaimer About Forward-Looking Statements & Third-Party Sources 3 Non-GAAP Financial Measures; Other Financial and Operational Data This presentation includes certain non-GAAP financial measures that are not prepared in accordance with accounting principles generally accepted in the United States
Slide 4: Table of Contents
I II ContextLogic Strategy Refresher gChem Overview III gChem Transaction Table of Contents IV Appendix
Slide 5: I. ContextLogic Strategy Refresher
I. ContextLogic Strategy Refresher
Slide 6: ContextLogic: A String of Pearls
ContextLogic: A String of Pearls ContextLogic’s vision is to build a collection of niche, competitively advantaged, long-duration businesses run by world-class management teams. Each business will operate in a decentralized structure, driving accountability, autonomy, and speed We intend to partner
Slide 7: Our Acquisition Strategy Is Focused on Three Clear Criteria
What we look for: Our Acquisition Strategy Is Focused on Three Clear Criteria... Niche Specialized businesses in small, growing markets Competitively Advantaged Businesses with “obvious” competitive differentiation Long Duration Asset Companies that are expected to earn good returns for many years t
Slide 8: Our Financial Model
We are targeting long-term 9–18% free cash flow1 per share growth on a sustained basis. Our Financial Model 5–10 % 9–18 % Targeted Long Term Free Cash Flow1 per share Growth 5–10 % Acquired Growth (1–2 %) Incentive Plan Dilution Organic Growth Note A reconciliation of projected long-term free cash f
Slide 9: II. Introducing The Second Pearl
II. Introducing The Second Pearl…
Slide 10: gChem Overview
gChem Overview A specialized portfolio serving mostly recession-resilient end markets, where gChem’s products are often “specified” into customers’ products. Gross Revenue Breakdown (2025A) gChem is a highly specialized business with a strong financial profile. Founded in 1962, gChem is a vertically
Slide 11: gChem Management Team
gChem Management Team gChem is led by a best-in-class management team with a strong track record. Source: Company information Joined as CEO in 2019 Profit has more than tripled under Frank’s leadership—through value pricing, product innovation, and operational discipline. Prior executive roles at A.
Slide 12: About DMSO
About DMSO Competitively Advantaged Long Duration Asset Niche Solvent Market Share Non- Toxicity Sustainability Polarity / Solubility¹ Strong Moderate Weak DMSO serves a specialized, demanding slice of the solvent market—DMSO is chosen for what it does, not what it costs. 331 million lbs. (2024) Oth
Slide 13: DMSO End-Market Applications
Semiconductors Strips photoresist and cleans silicon wafers during chip fabrication. Requires consistent ultra-clean quality; the smallest impurities can severely disrupt semiconductor production. Delivers active pharmaceutical ingredients into the body, and acts as a cryoprotectant in cell and gene
Slide 14: Vertical Integration and gChem's Competitive Advantages
Vertical Integration: Making DMSO means first making DMS, then NTO, then DMSO—three distinct on-site processes. gChem is the only on-purpose producer of DMS and NTO in North America. Closed–Loop Feedstock: gChem sources its H2S feedstock under a long-term contract with a co-located refinery at its o
Slide 15: Case Study #1: PROCIPIENT
Case Study #1: PROCIPIENT® About PROCIPIENT® Applications of PROCIPIENT® in the Human Body Long Duration Asset Competitively Advantaged Niche PROCIPIENT® is backed by the only active Type II Drug Master File for DMSO with the U.S. FDA with comparable filings in Europe and Canada. PROCIPIENT® is gChe
Slide 16: Case Study #2: Pharma Synthesis
Case Study #2: Pharma Synthesis Customer Requirements Key Case Study gChem’s DMSO is used in the synthesis of every GLP-1 therapy produced by a major pharmaceutical company. gChem has a long-standing relationship with this global business, collaborating directly on technical questions of DMSO storag
Slide 17: gChem's Financial Profile
Reported Operating Income1 gChem has compounded profit at ~19% per year – not by selling more, but by selling better. gChem’s Financial Profile Organic CAGR: ~19.2% Competitively Advantaged Long Duration Asset Niche Under current management, gChem has tripled profits since 2019—while becoming more s
Slide 18: Organic Growth Drivers
Organic Growth Drivers gChem serves end-markets with durable, long-term tailwinds — protein purification, cell and gene therapy and semiconductor spend. gChem also benefits directly as customers migrate away from toxic legacy solvents toward DMSO, a shift reinforced by tightening regulation. gChem w
Slide 19: Key Business Risks
Key Business Risks Considerations Primary Safeguards Single Plant The Tuscaloosa plant is highly automated, with 96–99%1 uptime in recent years. Advantaged inland location in Tuscaloosa, Alabama. Significant capex investments, a record of proactive and preventative maintenance, and a strong inspecti
Slide 20: III. gChem Transaction
Ill. gchem Transaction ® contextlogic 20
Slide 21: Detailed Transaction Overview
ContextLogic is acquiring gChem for $850 million in purchase price. Detailed Transaction Overview Note Sources & uses are preliminary and may change Includes management rollover Reflects illustrative transaction expenses as estimated at date of signing. Transaction Highlights Transaction Valuation C
Slide 22: ContextLogic Projected Free Cash Flow
ContextLogic Projected Free Cash Flow1 Free Cash Flow The transaction represents a meaningful growth in free cash flow. The transaction is attractive on the measure we most care about: free cash flow per unit. ~$95 - 105 million ~174 million Projected Free Cash Flow2 Total Units Outstanding at Holdi
Slide 23: IV. Appendix
IV. Appendix ® contextlogic 23)
Slide 24: Pre-Closing Capital Structure and Ownership Summary
Pre-Closing Capital Structure and Ownership Summary Structure Equity is held at two levels: ContextLogic Holdings Inc. (“PubCo”) and ContextLogic Holdings, LLC (“LLC”). Flexible capital structure, combined with long-term commitment from BC Partners and Abrams Capital. Abrams Capital is a 42% equityh
ContextLogic Holdings — Merger or Acquisition (August 2026) on 6ix